23.61 -0.21 (-0.88%)

38.06% Fall from 52W High

1.7M XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)



Board Meetings - Edgewise Therapeutics Inc

The next board meeting for Edgewise Therapeutics Inc is on 09 May 2025 for the purpose of Edgewise Therapeutics Inc First Quarter Earnings Results for 2025

Ex-date Purpose Notes
06 Jun 2025 Edgewise Therapeutics Inc Annual General Meeting for 2024 -
09 May 2025 Edgewise Therapeutics Inc First Quarter Earnings Results for 2025 -
11 Mar 2025 Leerink Partners Global Healthcare Conference -
07 Mar 2025 Edgewise Therapeutics Inc Annual Report for 2024 -
03 Mar 2025 Edgewise Therapeutics Inc Annual Report for 2024 -
03 Mar 2025 Edgewise Therapeutics Inc Fourth Quarter Earnings Results for 2024 -
28 Feb 2025 Edgewise Therapeutics Inc Annual Report for 2024 -
24 Feb 2025 Edgewise Therapeutics Inc Fourth Quarter Earnings Results for 2024 -
21 Feb 2025 Edgewise Therapeutics Inc Annual Report for 2024 -
21 Feb 2025 Edgewise Therapeutics Inc Fourth Quarter Earnings Results for 2024 -
13 Jan 2025 43rd Annual J.P. Morgan Healthcare Conference -
16 Dec 2024 Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker) -
03 Dec 2024 Edgewise Therapeutics Piper Sandler 36th Annual Healthcare Conference 2024 -
08 Nov 2024 Edgewise Therapeutics Inc Third Quarter Earnings Results for 2024 -
07 Nov 2024 Edgewise Therapeutics Inc Third Quarter Earnings Results for 2024 -
08 Oct 2024 29th International Annual Congress of the World Muscle Society -
19 Sep 2024 Edgewise Virtual Cardiovascular Event -
09 Aug 2024 Edgewise Therapeutics Inc Second Quarter Earnings Results for 2024 -
08 Aug 2024 Edgewise Therapeutics Inc Second Quarter Earnings Results for 2024 -
07 Jun 2024 Edgewise Therapeutics Inc Annual General Meeting for 2023 -
15 May 2024 RBC Capital Markets Global Healthcare Conference on May 15, 2024 -
13 May 2024 Edgewise Therapeutics Inc Patient Community Webinar -
10 May 2024 Edgewise Therapeutics Inc First Quarter Earnings Results for 2024 -
16 Apr 2024 Edgewise leadership to discuss ARCH findings -
02 Apr 2024 Cantor Virtual Muscular Dystrophy Symposium -
11 Mar 2024 Leerink Partners Global Biopharma Conference -
23 Feb 2024 Edgewise Therapeutics Inc Fourth Quarter Earnings Results for 2023 -
23 Feb 2024 Edgewise Therapeutics Inc Annual Report for 2023 -
22 Feb 2024 Edgewise Therapeutics Inc Annual Report for 2023 -
22 Feb 2024 Edgewise Therapeutics Inc Fourth Quarter Earnings Results for 2023 -
09 Nov 2023 Edgewise Therapeutics Inc Third Quarter Earnings Results for 2023 -
03 Nov 2023 Edgewise Therapeutics Inc Third Quarter Earnings Results for 2023 -
18 Oct 2023 Edgewise Community Webinar with PPMD: GRAND CANYON, a Phase 2 global pivotal study of EDG-5506 in individuals with Becker -
10 Aug 2023 Edgewise Therapeutics Inc Second Quarter Earnings Results for 2023 -
02 Aug 2023 MDA’s Clinician Industry Update Webinar: The Evolving Therapeutic Landscape for Becker Muscular Dystrophy: An Update – Part 2 -
27 Jun 2023 Edgewise Virtual Investor Event: 12-Month Topline Results from the ARCH Open Label Study of EDG-5506 in Adults with Becker Muscular Dystrophy -
09 Jun 2023 Edgewise Therapeutics Inc Annual General Meeting for 2022 -
08 Jun 2023 MDA’s Clinician Industry Update Webinar: The Evolving Therapeutic Landscape for Becker Muscular Dystrophy: An Update - Part 1 -
11 May 2023 Edgewise Therapeutics Inc First Quarter Earnings Results for 2023 -
03 May 2023 PPMD Webinar: Edgewise Therapeutics - A Novel Approach Designed to Protect Muscle in Becker Muscular Dystrophy -
29 Mar 2023 CureDuchenne Webinar with Edgewise Therapeutics: A Novel Approach to Protect Muscle in Duchenne -
23 Feb 2023 Edgewise Therapeutics Inc Annual Report for 2022 -
23 Feb 2023 Edgewise Therapeutics Inc Fourth Quarter Earnings Results for 2022 -
01 Feb 2023 MDA Community Industry Update Webinar: Edgewise Therapeutics -- A Novel Approach to Protect Muscle in Duchenne and Becker Muscular Dystrophy -
03 Jan 2023 Edgewise Virtual Investor Event: Novel Cardiac Program -
03 Nov 2022 Edgewise Therapeutics Inc Third Quarter Earnings Results for 2022 -
04 Aug 2022 Edgewise Therapeutics Inc Second Quarter Earnings Results for 2022 -
23 Jun 2022 Edgewise Therapeutics Inc Annual General Meeting for 2021 -
11 May 2022 Edgewise Therapeutics Inc First Quarter Earnings Results for 2022 -
24 Feb 2022 Edgewise Therapeutics Inc Fourth Quarter Earnings Results for 2021 -
24 Feb 2022 Edgewise Therapeutics Inc Annual Report for 2021 -
10 Nov 2021 Edgewise Therapeutics Inc Third Quarter Earnings Results for 2021 -
09 Aug 2021 Edgewise Therapeutics Inc Second Quarter Earnings Results for 2021 -
13 May 2021 Edgewise Therapeutics Inc First Quarter Earnings Results for 2021 -